Global Neutropenia Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

  • receipt Report ID : 139689
  • calendar_today Published On: Jan, 2019
  • file_copy Pages: 117
  • list Pharmaceuticals and Healthcare

Neutropenia is an abnormal condition, characterized by critically low levels of circulating neutrophils, a type of WBC found in the blood. These cells make up for the majority of circulating lymphocytes and help defend the body against infections by bacteria, viruses, and other pathogenic organisms. Decrease in the neutrophil count in blood makes a patient susceptible to infections and may even prove fatal. Therefore, the condition requires immediate prophylaxis.

Scope of the Report:

This report studies the Neutropenia Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Neutropenia Treatment market by product type and applications/end industries.

Novel therapies combined with growing cases of chemotherapy-induced neutropenia is one of the primary drivers for market growth. Moreover, the novel drug delivery technique also improves patient convenience leading to better patient adherence thus driving the market growth. Furthermore, since cancer is the known cause for developing neutropenia, the increasing cases of chemotherapy for the treatment of cancer will be a growth driver for the neutropenia treatment market.

The global Neutropenia Treatment market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Neutropenia Treatment.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Amgen

Novartis

Teva Pharmaceutical

Hospira

Pfizer

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Granulocyte -colony- stimulating factor (G-CSF)

Antibiotics

Antifungal drugs

Market Segment by Applications, can be divided into

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Neutropenia Treatment Market Overview

1.1 Product Overview and Scope of Neutropenia Treatment

1.2 Classification of Neutropenia Treatment by Types

1.2.1 Global Neutropenia Treatment Revenue Comparison by Types (2017-2023)

1.2.2 Global Neutropenia Treatment Revenue Market Share by Types in 2017

1.2.3 Granulocyte -colony- stimulating factor (G-CSF)

1.2.4 Antibiotics

1.2.5 Antifungal drugs

1.3 Global Neutropenia Treatment Market by Application

1.3.1 Global Neutropenia Treatment Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Hospital Pharmacy

1.3.3 Retail Pharmacy

1.3.4 Online Pharmacy

1.4 Global Neutropenia Treatment Market by Regions

1.4.1 Global Neutropenia Treatment Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Neutropenia Treatment Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Neutropenia Treatment Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Neutropenia Treatment Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Neutropenia Treatment Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Neutropenia Treatment Status and Prospect (2013-2023)

1.5 Global Market Size of Neutropenia Treatment (2013-2023)

2 Manufacturers Profiles

2.1 Amgen

2.1.1 Business Overview

2.1.2 Neutropenia Treatment Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Amgen Neutropenia Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.2 Novartis

2.2.1 Business Overview

2.2.2 Neutropenia Treatment Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Novartis Neutropenia Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.3 Teva Pharmaceutical

2.3.1 Business Overview

2.3.2 Neutropenia Treatment Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Teva Pharmaceutical Neutropenia Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.4 Hospira

2.4.1 Business Overview

2.4.2 Neutropenia Treatment Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Hospira Neutropenia Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.5 Pfizer

2.5.1 Business Overview

2.5.2 Neutropenia Treatment Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Pfizer Neutropenia Treatment Revenue, Gross Margin and Market Share (2016-2017)

3 Global Neutropenia Treatment Market Competition, by Players

3.1 Global Neutropenia Treatment Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Neutropenia Treatment Players Market Share

3.2.2 Top 10 Neutropenia Treatment Players Market Share

3.3 Market Competition Trend

4 Global Neutropenia Treatment Market Size by Regions

4.1 Global Neutropenia Treatment Revenue and Market Share by Regions

4.2 North America Neutropenia Treatment Revenue and Growth Rate (2013-2018)

4.3 Europe Neutropenia Treatment Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Neutropenia Treatment Revenue and Growth Rate (2013-2018)

4.5 South America Neutropenia Treatment Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Neutropenia Treatment Revenue and Growth Rate (2013-2018)

5 North America Neutropenia Treatment Revenue by Countries

5.1 North America Neutropenia Treatment Revenue by Countries (2013-2018)

5.2 USA Neutropenia Treatment Revenue and Growth Rate (2013-2018)

5.3 Canada Neutropenia Treatment Revenue and Growth Rate (2013-2018)

5.4 Mexico Neutropenia Treatment Revenue and Growth Rate (2013-2018)

6 Europe Neutropenia Treatment Revenue by Countries

6.1 Europe Neutropenia Treatment Revenue by Countries (2013-2018)

6.2 Germany Neutropenia Treatment Revenue and Growth Rate (2013-2018)

6.3 UK Neutropenia Treatment Revenue and Growth Rate (2013-2018)

6.4 France Neutropenia Treatment Revenue and Growth Rate (2013-2018)

6.5 Russia Neutropenia Treatment Revenue and Growth Rate (2013-2018)

6.6 Italy Neutropenia Treatment Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Neutropenia Treatment Revenue by Countries

7.1 Asia-Pacific Neutropenia Treatment Revenue by Countries (2013-2018)

7.2 China Neutropenia Treatment Revenue and Growth Rate (2013-2018)

7.3 Japan Neutropenia Treatment Revenue and Growth Rate (2013-2018)

7.4 Korea Neutropenia Treatment Revenue and Growth Rate (2013-2018)

7.5 India Neutropenia Treatment Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Neutropenia Treatment Revenue and Growth Rate (2013-2018)

8 South America Neutropenia Treatment Revenue by Countries

8.1 South America Neutropenia Treatment Revenue by Countries (2013-2018)

8.2 Brazil Neutropenia Treatment Revenue and Growth Rate (2013-2018)

8.3 Argentina Neutropenia Treatment Revenue and Growth Rate (2013-2018)

8.4 Colombia Neutropenia Treatment Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Neutropenia Treatment by Countries

9.1 Middle East and Africa Neutropenia Treatment Revenue by Countries (2013-2018)

9.2 Saudi Arabia Neutropenia Treatment Revenue and Growth Rate (2013-2018)

9.3 UAE Neutropenia Treatment Revenue and Growth Rate (2013-2018)

9.4 Egypt Neutropenia Treatment Revenue and Growth Rate (2013-2018)

9.5 Nigeria Neutropenia Treatment Revenue and Growth Rate (2013-2018)

9.6 South Africa Neutropenia Treatment Revenue and Growth Rate (2013-2018)

10 Global Neutropenia Treatment Market Segment by Type

10.1 Global Neutropenia Treatment Revenue and Market Share by Type (2013-2018)

10.2 Global Neutropenia Treatment Market Forecast by Type (2018-2023)

10.3 Granulocyte -colony- stimulating factor (G-CSF) Revenue Growth Rate (2013-2023)

10.4 Antibiotics Revenue Growth Rate (2013-2023)

10.5 Antifungal drugs Revenue Growth Rate (2013-2023)

11 Global Neutropenia Treatment Market Segment by Application

11.1 Global Neutropenia Treatment Revenue Market Share by Application (2013-2018)

11.2 Neutropenia Treatment Market Forecast by Application (2018-2023)

11.3 Hospital Pharmacy Revenue Growth (2013-2018)

11.4 Retail Pharmacy Revenue Growth (2013-2018)

11.5 Online Pharmacy Revenue Growth (2013-2018)

12 Global Neutropenia Treatment Market Size Forecast (2018-2023)

12.1 Global Neutropenia Treatment Market Size Forecast (2018-2023)

12.2 Global Neutropenia Treatment Market Forecast by Regions (2018-2023)

12.3 North America Neutropenia Treatment Revenue Market Forecast (2018-2023)

12.4 Europe Neutropenia Treatment Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Neutropenia Treatment Revenue Market Forecast (2018-2023)

12.6 South America Neutropenia Treatment Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Neutropenia Treatment Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure Neutropenia Treatment Picture

Table Product Specifications of Neutropenia Treatment

Table Global Neutropenia Treatment and Revenue (Million USD) Market Split by Prod

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery